Cangrelor

Kengrexal 50 MG Polvo Para Concentrado Para Solucion Inyectable y Para Perfusion

50 mg polvo para solución inyectable y para perfusiónSpainMarketedAuthorised 22 Mar 2018

In other countries

The same active substances on other registers, the same brand first.

KengrexalCanada · 50 MG / VIAL · Powder For Solution · Chiesi Farmaceutici S.P.A.Same brand
KengrexalEuropean Union · Chiesi Farmaceutici S.p.A.Same brand
KengrexalCroatiaSame brand
KengrexalItaly · Polvere per concentrato per soluzione iniettabile/infusione · Chiesi Farmaceutici S.P.A.Same brand
Kengrexal 50 mg poeder voor concentraat voor oplossing voor injectie / infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Chiesi Farmaceutici S.p.A.Same brand
KENGREXAL 50 mgRomania · 50mg · pulb. pt. conc. pt. sol. inj./perf. · Chiesi Farmaceutici S.P.A.Same brand
CangrelorUnited States · 50MG/VIAL · powder · GlandSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cangrelor

Kengrexal 50 MG Polvo Para Concentrado Para Solucion Inyectable y Para Perfusion

50 mg polvo para solución inyectable y para perfusiónSpainMarketedAuthorised 22 Mar 2018

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

KengrealUnited States · 50MG/VIAL · powder · Chiesi

Packs

Pack	Code	Status
KENGREXAL 50 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 10 viales	720608

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cangrelor
Strength: 50 mg
Dosage form: polvo para solución inyectable y para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 22 Mar 2018
Registration: 115994001
Marketing authorisation holder: Chiesi Farmaceutici S.P.A.
Procedure: EU centralised
Supply: Uso Hospitalario